CV19: vaccine development

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Klose, Karl

Funded by

Texas Biomedical Research Institute

Research Start Date

04/01/2020

Status

Inactive

Basic Research

Collaborative Project

Basic Research

Infectious Disease

Bioscience Research Panel